Ferredoxin gene mutation in Iranian Trichomonas vaginalis isolates

Iranian Journal of Parasitology

Volumn 8, Issue 3, 2013, Pages 402-407

  Heidari, Soudabeh ^a   Bandehpour, Mojgan ^a,b   Seyyed Tabaei, Seyyed Javad ^a   Valadkhani, Zarintaj ^c   Haghighi, Ali ^a   Abadi, Alireza ^a   Kazemi, Bahram ^a,b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Ferredoxin gene; Mutation; Trichomonas vaginalis

Indexed keywords

FERREDOXIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FERREDOXIN GENE; GENE; GENE MUTATION; GENE SEQUENCE; HUMAN; MUTATION RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

EID: 84884126467     PISSN: 17357020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wolner-Hanssen P, Krieger JN, Stevens CE, Kiviat NB, Koutsky L, Critchlow C, et al. Clinical manifestations of vaginal trichomo-niasis. JAMA. 1989;261:571-576.
2. Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol. 1984;150:965-972.
3. Markarian DS, Popova EA, Arshba AM, Sulukhiia RV, Cherkezila GK. Cases of Down's syndrome in children of young parents with choronic inflammatory genital diseases and secondary disorders of spermatogenesis. Akusb Ginekol (Mosk). 1990;5:38-41. [Article in Russian]
4. Hoffman DS, Brown GD, Wirth FH, Gebert BS, Bailey CL, Anday EK. Urinary tract infection with Trichomonas vaginalis in a premature newborn infant and the development of chronic lung disease. J Perinatol. 2003;23:59.
5. Super DE, Bumpt RC, Hurt WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factor for colitis after abdominal hysterectomy. Am J Obstet Gynecol. 1990;163(3):1016-1023.
6. Holmes KK, Handsfield HH, Wang SP, Wentworth BB, Turck M, Anderson JB, et al. Etiology of nongonococcal urethritis. N Engl J Med. 1975;292:1199-1205.
7. Mardh PA, Colleen S. Search for uro-genital tract infections in patients with symptoms of prostatitis. Studies on aerobic and strictly anae-robic bacteria, mycoplasmas, fungi, tricho-monads and viruses. Scand J Urol Nephrol. 1975;9:8-16.
8. Han Q, Liu J, Wang T, Xiao H, Fang Z. Influence of the metabolite produced by Trichomonas vaginalis on human sperm motility in vitro. Zhonghua Nan Ke Xue. 2004;10(4):272-274.
9. Nicoletti N. The problem of trichomoniasis of the lower genital tract in the female. Br J Vener Dis. 1961;37:223-228.
10. Zhang ZF, Graham S, Yu SZ, Marshall J, Zie-lezny M, Chen YX, et al. Trichomonas vaginalis and cervical cancer. A prospective study in China. Ann Epidemiol. 1995;5:325-332.
11. Cosar C, Julou L. Activity of 1-(2-hydrox-yethyl)-2-methyl-5- nitroimidazole (R.P. 8823) against experimental Trichomonas vaginalis infection. Ann Inst Pasteur. 1959;96:238-241. [Article in French]
12. Edwards DI. Nitroimidazole drugs-action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother. 1993;31:9-20
13. Chapman A, Cammack R, Linstead D, Lloyd D. The generation of metronidazole radicals in hydrogenosomes isolated from Trichomonas vaginalis. J Gen Microbiol. 1985;131:2141-2144.
14. Robinson SC. Trichomonal vaginitis resistant to metronidazole. Can Med Assoc J. 1962;86:665.
15. Lossick JG. Therapy of urogenital trichomo-niasis,. In Honigberg B M(ed.), Trichomonads parasitic in man. Springer Verlag, New York;1989. p. 324-341.
16. Sobel JD, Nagappan V, Nyirjesy P. Metroni-dazole-resistant vaginal trichomoniasis -an emerging problem. N Engl J Med. 1999;341(4):292-293.
17. Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev. 2001;14(1):150.
18. Schwebke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother. 2006;50(12):4209-4210.
19. Land KM, Clemens DL, Johnson PJ. Loss of multiple hydrogenosomal proteins associated with organelle metabolism and high-level drug resistance in trichomonads. Exp Parasitol. 2001;97(2):102-110.
20. Rasoloson D, Vanacova S, Tomkova E, Razga J, Hrdy I, Tachezy J, et al. Mechanisms of in vitro development of resistance to metro-nidazole in Trichomonas vaginalis. Microbiology. 2002;148:2467-2477.
21. Diamond LS, Harlow DR, Cunnick CC. A new medium for the axenic culture of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 1978;72(4):431-432.
22. Quon DV, d'Oliveira CE, Johnson PJ. Reduced transcription of the ferredoxin gene in metronidazole - resistant Trichomonas vaginalis. Proc Natl Acad Sci USA. 1992;89:4402-4406.
23. Vidakovic M, Crossnoe CR, Neidre C, Kim K, Krause KL, Germanas JP. Reactivity of reduced [2Fe-2S[ferredoxins parallels host susceptibility to nitroimidazoles. Antimicrob Agents Chemother. 2003;47:302-308.
24. Land KM, Delgadillo-Correa MG, Tachezy J, Vanacova S, Hseih CL, Sutak R, et al. Targeted gene replacement of a ferredoxin gene in Trichomonas vaginalis does not lead to metronidazole resistance. Mol Microbiol. 2004;51:115-122.